Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership
Cannabis Law Report
JUNE 28, 2021
Our expertise in neurology and Curaleaf International’s knowledge of the pharmaceutical active processes of cannabinoids provide ideal conditions to bring innovative treatment to patients,” says Marco Castino, Head of Region Europe in Zambon. billion 1 by 2025. The market for medical cannabis in Germany. 1 Brightfield Group 2020.
Let's personalize your content